Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Harro, J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 47 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Damberg, M; Eller, M; Tonissaar, M; Oreland, L; Harro, J
      Levels of transcription factors AP-2 alpha and AP-2 beta in the brainstem are correlated to monoamine turnover in the rat forebrain

      NEUROSCIENCE LETTERS
    2. Harro, M; Eensoo, D; Kiive, E; Merenakk, L; Alep, J; Oreland, L; Harro, J
      Platelet monoamine oxidase in healthy 9-and 15-years old children: The effect of gender, smoking and puberty

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    3. Harro, J; Tonissaar, M; Eller, M
      The effects of CRA 1000, a non-peptide antagonist of corticotropin-releasing factor receptor type 1, on adaptive behaviour in the rat

      NEUROPEPTIDES
    4. Harro, J; Tonissaar, M; Eller, M; Kask, A; Oreland, L
      Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry

      BRAIN RESEARCH
    5. Harro, J; Merikula, A; Lepiku, M; Modiri, AR; Rinken, A; Oreland, L
      Lesioning of Locus coeruleus projections by DSP-4 neurotoxin treatment: Effect on amphetamine-induced hyperlocomotion and dopamine D-2 receptor binding in rats

      PHARMACOLOGY & TOXICOLOGY
    6. Prince, JA; Harro, J; Blennow, K; Gottfries, CG; Oreland, L
      Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics

      NEUROPSYCHOPHARMACOLOGY
    7. Kask, A; Eller, M; Oreland, L; Harro, J
      Neuropeptide Y attenuates the effect of locus coeruleus denervation by DSP-4 treatment on social behaviour in the rat

      NEUROPEPTIDES
    8. Kask, A; Harro, J
      Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide YY1 receptor antagonist BIBO 3304

      NEUROPHARMACOLOGY
    9. Kask, A; Schioth, HB; Harro, J; Wikberg, JES; Rago, L
      Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide YY1 receptor selective antagonists

      CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    10. Harro, J; Haidkind, R; Harro, M; Modiri, AR; Gillberg, PG; Pahkla, R; Matto, V; Oreland, L
      Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    11. Harro, J; Rimm, H; Harro, M; Grauberg, M; Karelson, K; Viru, AM
      Association of depressiveness with blunted growth hormone response to maximal physical exercise in young healthy men

      PSYCHONEUROENDOCRINOLOGY
    12. Harro, J; Pahkla, R; Modiri, AR; Harro, M; Kask, A; Oreland, L
      Dose-dependent effects of noradrenergic denervation by DSP-4 treatment on forced swimming and beta-adrenoceptor binding in the rat

      JOURNAL OF NEURAL TRANSMISSION
    13. Kask, A; Kivastik, T; Rago, L; Harro, J
      Neuropeptide YY1 receptor antagonist BIBP3226 produces conditioned place aversion in rats

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    14. KASK A; RAGO L; HARRO J
      NPY Y-1 RECEPTORS IN THE DORSAL PERIAQUEDUCTAL GRAY-MATTER REGULATE ANXIETY IN THE SOCIAL-INTERACTION TEST

      NeuroReport
    15. LOFBERG C; AGREN H; HARRO J; ORELAND L
      CHOLECYSTOKININ IN CSF FROM DEPRESSED-PATIENTS - POSSIBLE RELATIONS TO SEVERITY OF DEPRESSION AND SUICIDAL-BEHAVIOR

      European neuropsychopharmacology
    16. KASK A; HARRO J; RAGO L
      OPPOSITE EFFECTS OF [LEU(13),PRO(34)]NPY AND NPY(13-36) ON HYPNOTIC RESPONSE TO ALPHA(2)-ADRENOCEPTOR AGONIST DEXMEDETOMIDINE MICROINJECTEDINTO RAT LOCUS-COERULEUS

      Neuroscience research communications
    17. KASK A; RAGO L; HARRO J
      ANXIOGENIC-LIKE EFFECT OF THE NPY Y-1 RECEPTOR ANTAGONIST BIBP3226 ADMINISTERED INTO THE DORSAL PERIAQUEDUCTAL GRAY-MATTER IN RATS

      Regulatory peptides
    18. LOFBERG C; HARRO J; MATTO V; ORELAND L
      CHOLECYSTOKININ PEPTIDES AND RECEPTOR-BINDING IN RAT-BRAIN AFTER DSP-4 TREATMENT

      Neuropeptides
    19. KASK A; RAGO L; HARRO J
      EVIDENCE FOR INVOLVEMENT OF NEUROPEPTIDE-Y RECEPTORS IN THE REGULATION OF FOOD-INTAKE - STUDIES WITH Y-1-SELECTIVE ANTAGONIST BIBP3226

      British Journal of Pharmacology
    20. RINKEN A; HARRO J; ENGSTROM L; ORELAND L
      ROLE OF FLUIDITY OF MEMBRANES ON THE GUANYL NUCLEOTIDE-DEPENDENT BINDING OF CHOLECYSTOKININ-8S TO RAT-BRAIN CORTICAL MEMBRANES

      Biochemical pharmacology
    21. KASK A; RAGO L; HARRO J
      ANXIOLYTIC-LIKE EFFECT OF NEUROPEPTIDE Y(NPY) AND NPY13-36 MICROINJECTED INTO VICINITY OF LOCUS-COERULEUS IN RATS

      Brain research
    22. KASK A; RAGO L; HARRO J
      ALPHA-HELICAL CRF9-41 PREVENTS ANXIOGENIC-LIKE EFFECT OF NPY Y-1 RECEPTOR ANTAGONIST BIBP3226 IN RATS

      NeuroReport
    23. MATTO V; HARRO J; ALLIKMETS L
      THE EFFECT OF DRUGS ACTING ON CCK RECEPTORS AND RAT FREE EXPLORATION IN THE EXPLORATION BOX

      Journal of Physiology and Pharmacology
    24. OTTER MH; MATTO V; SOUKAND R; SKREBUHHOVA T; ALLIKMETS L; HARRO J
      CHARACTERIZATION OF RAT EXPLORATORY-BEHAVIOR USING THE EXPLORATION BOX TEST

      Methods and findings in experimental and clinical pharmacology
    25. MATTO V; HARRO J; ALLIKMETS L
      THE EFFECTS OF CHOLECYSTOKININ-A AND CHOLECYSTOKININ-B RECEPTOR ANTAGONISTS ON EXPLORATORY-BEHAVIOR IN THE ELEVATED ZERO-MAZE IN RAT

      Neuropharmacology
    26. KASK A; HARRO J; TUOMAINEN P; RAGO L; MANNISTO PT
      OVERFLOW OF NORADRENALINE AND DOPAMINE IN FRONTAL-CORTEX AFTER [N-(2-CHLOROETHYL)-N-ETHYL-2-BROMOBENZYLAMINE] (DSP-4) TREATMENT - IN-VIVO MICRODIALYSIS STUDY IN ANESTHETIZED RATS

      Naunyn-Schmiedeberg's archives of pharmacology
    27. HARRO J; LOFBERG C; PAHKLA R; MATTO V; RAGO L; ORELAND L; ALLIKMETS L
      DIFFERENT MOLECULAR-FORMS OF CHOLECYSTOKININ AND CCKB RECEPTOR-BINDING IN THE RAT-BRAIN AFTER CHRONIC ANTIDEPRESSANT TREATMENT

      Naunyn-Schmiedeberg's archives of pharmacology
    28. PAHKLA R; HARRO J; RAGO L
      BEHAVIORAL-EFFECTS OF PINOLINE IN THE RAT FORCED SWIMMING, OPEN-FIELDAND ELEVATED PLUS-MAZE TESTS

      Pharmacological research
    29. HARRO J; ORELAND L
      DEPRESSION AS A SPREADING NEURONAL ADJUSTMENT DISORDER

      European neuropsychopharmacology
    30. MATTO V; HARRO J; ALLIKMETS L
      THE EFFECTS OF CHOLECYSTOKININ-A AND CHOLECYSTOKININ-B RECEPTOR ANTAGONISTS, DEVAZEPIDE AND L-365260, ON CITALOPRAM-INDUCED DECREASE OF EXPLORATORY-BEHAVIOR IN RAT

      Journal of Physiology and Pharmacology
    31. LOFBERG C; HARRO J; GOTTFRIES CG; ORELAND L
      CHOLECYSTOKININ PEPTIDES AND RECEPTOR-BINDING IN ALZHEIMERS-DISEASE

      Journal of neural transmission
    32. ALLIKMETS L; MATTO V; HARRO J
      ANXIOGENIC COMPONENT IN THE MECHANISM OF ACTION OF ANTIDEPRESSANTS ISESSENTIAL FOR CLINICAL EFFECT

      Naunyn-Schmiedeberg's archives of pharmacology
    33. MATTO V; ALLIKMETS L; HARRO J
      THE EFFECT OF CCKA AND CCKB RECEPTOR ANTAGONISTS ON RAT EXPLORATORY-BEHAVIOR IN THE ELEVATED ZERO-MAZE

      Naunyn-Schmiedeberg's archives of pharmacology
    34. HARRO J; LOFBERG C; REHFELD JF; ORELAND L
      CHOLECYSTOKININ PEPTIDES AND RECEPTORS IN THE RAT-BRAIN DURING STRESS

      Naunyn-Schmiedeberg's archives of pharmacology
    35. KASK A; RAGO L; HARRO J
      ANXIOGENIC-LIKE EFFECT OF THE NEUROPEPTIDE-Y Y-1 RECEPTOR ANTAGONIST BIBP3226 - ANTAGONISM WITH DIAZEPAM

      European journal of pharmacology
    36. ALLIKMETS L; MATTO V; HARRO J
      DO THE ANTIDEPRESSANTS HAVE ANXIOGENIC ACTION

      Biological psychiatry
    37. HARRO J; ORELAND L; VASAR E; BRADWEJN J
      IMPAIRED EXPLORATORY-BEHAVIOR AFTER DSP-4 TREATMENT IN RATS - IMPLICATIONS FOR THE INCREASED ANXIETY AFTER NORADRENERGIC DENERVATION

      European neuropsychopharmacology
    38. LANG A; HARRO J; SOOSAAR A; KOKS S; VOLKE V; ORELAND L; BOURIN M; VASAR E; BRADWEJN J; MANNISTO PT
      ROLE OF N-METHYL-D-ASPARTIC ACID AND CHOLECYSTOKININ RECEPTORS IN APOMORPHINE-INDUCED AGGRESSIVE-BEHAVIOR IN RATS

      Naunyn-Schmiedeberg's archives of pharmacology
    39. HARRO J; WAHLSTROM G; ORELAND L
      CHOLECYSTOKININ RECEPTOR-BINDING AFTER LONG-TERM ETHANOL TREATMENT INRATS

      Alcohol and alcoholism
    40. WELIN M; HARRO J; YUKHANANOV R; NYBERG F; ORELAND L
      CHOLECYSTOKININ RECEPTOR-BINDING IN MORPHINE ANALGESIA - TOLERANCE, WITHDRAWAL AND ABSTINENCE

      Neuropeptides
    41. VASAR E; LANG A; HARRO J; KOKS S; VOLKE V; SIHVER S; BOURIN M; BRADWEJN J; MANNISTO PT
      SUBDIAPHRAGMATIC VAGOTOMY DOES NOT PREVENT THE ANTI-EXPLORATORY EFFECT OF CERULEIN IN THE ELEVATED PLUS-MAZE

      Neuropeptides
    42. SHERIF F; HARRO J; ELHWUEGI A; ORELAND L
      ANXIOLYTIC-LIKE EFFECT OF THE GABA-TRANSAMINASE INHIBITOR VIGABATRIN (GAMMA-VINYL GABA) ON RAT EXPLORATORY ACTIVITY

      Pharmacology, biochemistry and behavior
    43. VASAR E; LANG A; HARRO J; BOURIN M; BRADWEJN J
      EVIDENCE FOR POTENTIATION BY CCK ANTAGONISTS OF THE EFFECT OF CHOLECYSTOKININ-OCTAPEPTIDE IN THE ELEVATED PLUS-MAZE

      Neuropharmacology
    44. MANNISTO PT; LANG A; HARRO J; PEURANEN E; BRADWEJN J; VASAR E
      OPPOSITE EFFECTS MEDIATED BY CCKA AND CCKB RECEPTORS IN BEHAVIORAL AND HORMONAL STUDIES IN RATS

      Naunyn-Schmiedeberg's archives of pharmacology
    45. VASAR E; LANG A; HARRO J; BRADWEJN J; MANNISTO PT
      OPPOSITE EFFECTS MEDIATED BY CCKA AND CCKB RECEPTORS UPON THE REGULATION OF BEHAVIOR AND HORMONAL SECRETION IN RODENTS

      Journal of physiology
    46. HARRO J; WESTERLING P; ORELAND L
      CCK(B) RECEPTOR ACTIVATION REDUCES GLUTAMATE-INDUCED DEPOLARIZATION IN SLICES OF RAT CEREBRAL-CORTEX

      Journal of neural transmission
    47. HARRO J; VASAR E; BRADWEJN J
      CCK IN ANIMAL AND HUMAN RESEARCH ON ANXIETY

      Trends in pharmacological sciences


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 17:33:55